OGRD Alliance Hero Section
OGRDALLIANCE
Science for a healthier human tomorrow
INVEST & PARTNER →
EN ▾

Science Built.
Assets Connected.
A Healthier Tomorrow.

OGRD Alliance develops and connects innovative assets in biotechnology, precision medicine, MedTech, specialized nutrition and functional evidence to transform access to therapies that improve the lives of people worldwide.

EXPLORE OUR PLATFORM → INVEST & PARTNER →
6
Platform Verticals
2
Global Hubs
(US & Dubai)
5+
International Partners
1
Purpose
Better Human Health
PEOPLE
SCIENCE
PARTNERSHIPS
A BRIGHTER
TOMORROW
FROM MOLECULAR INSIGHT
TO A HEALTHIER TOMORROW

Our Platform Assets

Distinct solutions. A shared scientific core. Multiple opportunities.

VIEW ALL ASSETS →
PLPC-DB Biopharma

PLPC-DB™

Biopharma · Immunobiology

Phospholipid complex for immune modulation and precision applications.

LEARN MORE →
IMMUNOLOGY
ONCOVIX Clinical Platform

ONCOVIX™

Clinical Platform

Longitudinal architecture for personalized oncology and multidisciplinary care.

LEARN MORE →
ONCOLOGY
APHELAR MedTech

APHELAR™

MedTech · Interface Engineering

Skin-interface microstructured patch for a new generation of therapies.

LEARN MORE →
DERMATOLOGY
ABIMPROSYC Nutrition

ABIMPROSYC™

Specialized Nutrition

Four functional systems (T-Defense™, Resilia™, Sport™, Vitalis™) in AM/PM formulations.

LEARN MORE →
NUTRITION
STIP Human Functional Evidence

STIP™

Human Functional Evidence

Traceability, comparability and functional profiling. 48h · 8 human lines · 504 runs.

LEARN MORE →
EVIDENCE
SPACE Mission Health

SPACE

Mission Health

From immunobiology to human resilience in extreme environments.

LEARN MORE →
GLOBAL HEALTH

PLPC™
Microdomain Science™

A common scientific foundation.
Multiple expressions of value.

PLPC™ explores how molecular organization, membrane microdomains and biological interfaces drive function, and translates this knowledge into assets with real-world impact.

STRUCTURE • INTERFACE • SIGNALING • FUNCTION
PLPC Microdomain Science Diagram
"Biology is not only about what molecules exist, but how they are organized, how they interact and what they make possible."

From Scientific Knowledge to Real-World Impact

A continuous path from molecular understanding to healthier lives.

From Scientific Knowledge to Real-World Impact Flowchart
DIFFERENT SCALES.
A COMMON PURPOSE.
MEASURABLE IMPACT.

Platform Evolution Timeline

From scientific infrastructure to regulatory validation and asset expansion.

🔬
2016
Core scientific and operational infrastructure
🤝
2017–2018
CORFO programs - agreement with University of Concepción
📊
2019
Program completion and capability consolidation
👥
2020–2024
Translational development - human experience - RWD - STIP™ maturation
📄
2025
Peer-reviewed scientific publications: Biomedicines, IJMS, Biology
🏛️
2025
International congresses: ASCO, ESMO, SITC, CAP
📋
Jul 2025
CTD / FDA-readiness dossier consolidation
🛡️
Aug 18, 2025
Veristat: independent gap analysis
⚖️
Sep 15, 2025
Freyr: technical position letter / Pre-IND review
👥
2026
Corporate book: strategic platform value architecture & market benchmark
🌐
2026
Corporate book: strategic platform value architecture
🌐
Aug 2026
APHELAR™: HSA Singapore Class A Product Notification
📈
2026
Platform expansion: PLPC-DB™, ONCOVIX™, APHELAR™, ABIMPROSYC™, STIP™ and Space

Our Global Reach

Scientific depth. Local execution. Global impact.

Global Reach Map
Global Hubs & Locations
LOCAL CAPABILITIES.
GLOBAL REACH.
REAL IMPACT.
Scroll al inicio